As part of its healthcare investment platform, Lian Group acquired Scientis, a pioneering Swiss cosmeceutical company.WHO: Scientis is a Swiss dermatology company dedicated to skin pigmentation with its flagship product Cyspera. The Cyspera range contains the proprietary Cysteamine Isobionic-Amide Complex, a clinically proven pigment corrector. The company is ready for global market penetration, building on a strong established presence in Asia and the US.Lian Group is an investment firm building and funding successful companies in the most impactful industries while collaborating closely with accomplished entrepreneurial leaders. They generate value by investing not just money but also time and expertise, with a focus on opportunities in healthcare, and digital assets and infrastructure. WHY: This acquisition signifies Lian Group's commitment to expanding its healthcare platform into the beauty and well-being sectors, where further acquisitions are planned and ready to be executed. The Lian team will work hand-in-hand with Scientis to unlock the company's potential and grow into a leader in the cosmeceutical industry.IN THEIR OWN WORDS: "We are thrilled to welcome Scientis to Lian Group's healthcare platform. With our hands-on approach, we are committed to accelerating Scientis' growth and sales in new markets. We will support management by leveraging our network, expertise and resources to expand into new markets, streamline operations, develop innovative products and services, and empower patients and healthcare professionals with high-quality solutions." says Fiorenzo Manganiello, Managing Partner of Lian Group.